First FDA approved medicine to treat all forms of Diabetic Retinopathy

Innoplexus > Diseases  > First FDA approved medicine to treat all forms of Diabetic Retinopathy

First FDA approved medicine to treat all forms of Diabetic Retinopathy

The U.S. Food and Drug Administration has approved Lucentis (ranibizumab injection) for Diabetic Retinopathy which is the leading cause of vision loss among working aged adults. With this approval, Lucentis has become the first and only medicine to treat Diabetic Retinopathy in patients with or without diabetic macular edema (DME).

Share this Image On Your Site

Admin
Book a Demo Book a Demo